Relevant bibliographies by topics / Thrombocytopenic Purpura

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Thrombocytopenic Purpura'

Author: Grafiati
Published: 4 June 2021
Last updated: 26 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Thrombocytopenic Purpura.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Thrombocytopenic Purpura"

1

Stein, Richard S. "Persistently Perplexing Purpuras: Thrombotic Thrombocytopenic Purpura and Immune Thrombocytopenic Purpura." Annals of Internal Medicine 121, no. 9 (1994): 720. http://dx.doi.org/10.7326/0003-4819-121-9-199411010-00019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Stricker, Raphael B. "Persistently Perplexing Purpuras: Thrombotic Thrombocytopenic Purpura and Immune Thrombocytopenic Purpura." Annals of Internal Medicine 121, no. 9 (1994): 720. http://dx.doi.org/10.7326/0003-4819-121-9-199411010-00031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zucker-Franklin, Dorothea. "Persistently Perplexing Purpuras: Thrombotic Thrombocytopenic Purpura and Immune Thrombocytopenic Purpura." Annals of Internal Medicine 121, no. 9 (1994): 720. http://dx.doi.org/10.7326/0003-4819-121-9-199411010-00032.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Schattner, Elaine. "Persistently Perplexing Purpuras: Thrombotic Thrombocytopenic Purpura and Immune Thrombocytopenic Purpura." Annals of Internal Medicine 121, no. 9 (1994): 720. http://dx.doi.org/10.7326/0003-4819-121-9-199411010-00033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

., Alvina, and Diana Aulia. "IDIOPATHIC THROMBOCYTOPENIC PURPURA." INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 16, no. 3 (2018): 149. http://dx.doi.org/10.24293/ijcpml.v16i3.1036.

Full text
Abstract:
Idiopathic thrombocytopenic purpura is an autoimunne disease with low platelet count and bleeding manifestation like purpura, echymosis, petechie, mucosa membrane bleeding. The cause of ITP is platelet coated with specific thrombocyte autoantibody. Idiopathicthrombocytopenic purpura is classified as primary or secondary. The primary ITP is classified as acute and chronic.. Children and adultonset idiopathic thrombocytopenic purpura are different. An Acute ITP can be found in children and chronic onset can be found in adult.The duration of bleeding may help to distinguish acute and chronic idio
APA, Harvard, Vancouver, ISO, and other styles
6

Bennani Kenza, Tlamçani Imane, and Amrani Hassani Moncef. "Immune thrombocytopenic purpura in children: An update." World Journal of Advanced Research and Reviews 23, no. 2 (2024): 1456–61. http://dx.doi.org/10.30574/wjarr.2024.23.2.2485.

Full text
Abstract:
Immune thrombocytopenic purpura, also known as Werlhof's disease, is the most common cause of thrombocytopenia in children. While the majority of childhood Immune thrombocytopenic purpura cases are benign and resolve spontaneously, a rigorous evaluation of bleeding potential using the Buchanan score remains essential. Indeed, in rare situations, the disease can progress to severe forms threatening life prognosis. The diagnosis of immune thrombocytopenic purpura relies on a combination of clinical, biological criteria, and exclusion of other causes of thrombocytopenia. Management of Immune thro
APA, Harvard, Vancouver, ISO, and other styles
7

Bennani, Kenza, Imane Tlamçani, and Hassani Moncef Amrani. "Immune thrombocytopenic purpura in children: An update." World Journal of Advanced Research and Reviews 23, no. 2 (2024): 1456–61. https://doi.org/10.5281/zenodo.14859400.

Full text
Abstract:
Immune thrombocytopenic purpura, also known as Werlhof's disease, is the most common cause of thrombocytopenia in children. While the majority of childhood Immune thrombocytopenic purpura cases are benign and resolve spontaneously, a rigorous evaluation of bleeding potential using the Buchanan score remains essential. Indeed, in rare situations, the disease can progress to severe forms threatening life prognosis. The diagnosis of immune thrombocytopenic purpura relies on a combination of clinical, biological criteria, and exclusion of other causes of thrombocytopenia. Management of Immune thro
APA, Harvard, Vancouver, ISO, and other styles
8

Ge, Hangping, Zhan Shi, Zhiyin Zheng, et al. "Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report." Journal of International Medical Research 50, no. 3 (2022): 030006052210851. http://dx.doi.org/10.1177/03000605221085127.

Full text
Abstract:
A 33-year-old Chinese woman with a history of immune thrombocytopenic purpura presented with heavy menstrual bleeding. She was found to have thrombocytopenia, plasma ADAMTS13 activity of 0%, and positivity for the plasma ADAMTS13 inhibitor. She was diagnosed with the coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura. The patient was treated by plasmapheresis, a glucocorticoid, and rituximab. Her platelet level returned to normal, and she was discharged 28 days after admission. The number of plasmapheresis sessions and the timing of rituximab administration
APA, Harvard, Vancouver, ISO, and other styles
9

Yalaz, Mehmet, Mehmet T. Arslan, and Zafer Kurugöl. "Thrombocytopenic purpura as only manifestation of brucellosis in a child." Turkish Journal of Pediatrics 46, no. 3 (2004): 265–67. http://dx.doi.org/10.24953/turkjped.2004.2815.

Full text
Abstract:
Thrombocytopenic purpura associated with brucellosis has been rarely reported in the world literature. Thrombocytopenic purpura is generally part of the array of manifestations of brucellosis such as fever, arthritis, malaise and hepatosplenomegaly. We describe a nine-year-old girl who presented with thrombocytopenic purpura as the sole manifestation of brucellosis, which resolved with anti-Brucella chemotherapy. Her physical examination was remarkable for hepatomegaly of 3 cm and splenomegaly of 2 cm palpable below the costal margin. Initial laboratory investigations revealed isolated thrombo
APA, Harvard, Vancouver, ISO, and other styles
10

Dickey, Marcus SR, Anant J. Raina, Peter J. Gilbar, et al. "Pembrolizumab-induced thrombotic thrombocytopenic purpura." Journal of Oncology Pharmacy Practice 26, no. 5 (2019): 1237–40. http://dx.doi.org/10.1177/1078155219887212.

Full text
Abstract:
Introduction Pembrolizumab is a humanised monoclonal antibody targeting the receptor programmed cell death protein-1 (PD-1), with anti-tumour activity demonstrated for many malignancies. Such immune checkpoint inhibitors are associated with many immune-related adverse events including rash, colitis, hepatitis, pneumonitis, endocrinopathy and, rarely, haematological adverse events, including immune-related thrombocytopenia. Case report We report a 60-year-old female with metastatic non-small cell lung cancer treated with pembrolizumab every three weeks. Following her fifth cycle, she presented
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Thrombocytopenic Purpura"

1

Scully, Marie Ann. "The pathogenesis of thrombotic Thrombocytopenic Purpura." Thesis, University College London (University of London), 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.498417.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wenger, Martin. "Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura /." [S.l : s.n.], 1994. http://www.ub.unibe.ch/content/bibliotheken_sammlungen/sondersammlungen/dissen_bestellformular/index_ger.html.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mancini, I. "ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA." Doctoral thesis, Università degli Studi di Milano, 2013. http://hdl.handle.net/2434/217173.

Full text
Abstract:
Thrombotic thrombocytopenic purpura (TTP) is a rare but life-threatening microangiopathic disorder, due to the persistence of highly thrombogenic ultra large (UL) von Willebrand factor (VWF) multimers in the microcirculation. TTP is associated with the severe deficiency of ADAMTS13 (activity <10%), the metalloprotease responsible for the proteolytic regulation of VWF multimers size. In the acquired form of the disease, the severe deficiency of ADAMTS13 is caused by anti-ADAMTS13 antibodies that inhibit ADAMTS13 activity (neutralizing anti-ADAMTS13 antibodies or inhibitors) and/or increase its
APA, Harvard, Vancouver, ISO, and other styles
4

Treutiger, Iris. "Idiopathic thrombocytopenic purpura in childhood : clinical features, diagnostics and treatment /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7140-084-2/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Najaoui, Abderrahim [Verfasser]. "Komplement-Bindende Autoantikörper in immune thrombocytopenic purpura / Abderrahim Najaoui." Gießen : Universitätsbibliothek, 2011. http://d-nb.info/1063111390/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hon, Fung-yan, and 韓鳳恩. "The clinical utility of ADAMTS13 assays in the diagnosis of thromboticthrombocytopenic purpura." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46699740.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lam, Wang-hoi, and 林宏凱. "ADAMTS13 assays in thrombotic microangiopathy." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48334029.

Full text
Abstract:
Thrombotic microangiopathy is featured by microangiopathic haemolytic anaemia, thrombocytopenia and the presence of peripheral fragmented red cells. Thrombotic thrombocytopenic purpura (TTP) is the major disease entity of concern, which is caused by a congenital or acquired deficiency of a von Willebrand factor (vWF) cleaving protease known as ADAMTS13 (A Disintegrin And Metalloprotease with Thrombospondin type 1 motif, member 13). Deficiency of this protease, leads to accumulation of uncleaved ultra-large hyperactive vWF multimers in peripheral circulation causing the extensive microvascular
APA, Harvard, Vancouver, ISO, and other styles
8

Houwerzijl, Ewout Johan. "Studies on megakaryopoiesis in patients with myelodysplasia and idiopathic thrombocytopenic purpura." [S.l. : Groningen : s.n. ; University Library of Groningen] [Host], 2008. http://irs.ub.rug.nl/ppn/306088665.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cooper, Nichola. "Investigating the therapeutic options and pathobiology of immune thrombocytopenic purpura in adults." Thesis, Queen Mary, University of London, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.424696.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Karpman, Diana O. "Studies of the pathogenesis of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura." Lund : Lund University, 1997. http://catalog.hathitrust.org/api/volumes/oclc/68945090.html.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Thrombocytopenic Purpura"

1

Paul, Imbach, and Workshop on Immunoglobulin (1985 : :Lucerne, Switzerland), eds. Idiopathic thrombocytopenic purpura: Proceedings of a workshop. PharmaLibri, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

1941-, Kaplan Bernard S., Trompeter Richard S, and Moake Joel L. 1940-, eds. Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Marcel Dekker, Inc., 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Handelsman, Harry. Protein A columns for immune thrombocytopenia. U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Parker, James N., and Philip M. Parker. The official patient's sourcebook on immune thrombocytopenic purpura. Icon Health Publications, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

H, Waters A., Webster A. D. B, Sandoz Pharmaceuticals, Medi-Cine Communications International, and Royal Society of Medicine (Great Britain), eds. Intravenous immunoglobulins in immunodeficiency syndromes and idiopathic thrombocytopenic purpura. Royal Society of Medicine, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hewitt, John. Studies in antibody specificity against platelet glycoprotein IIb/IIIa in autoimmune thrombocytopenic purpura. University of Manchester, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Parker, James N., and Philip M. Parker. Thrombotic thrombocytopenic purpura: A bibliography and dictionary for physicians, patients, and genome researchers [to Internet references]. ICON Health Publications, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Scully, Marie A., and Spero R. Cataland. Fast Facts: Thrombotic Thrombocytopenic Purpura. Karger AG, S., 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Scully, Marie A., and Spero R. Cataland. Fast Facts: Thrombotic Thrombocytopenic Purpura. Karger AG, S., 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lewis, David Charles. Canine idiopathic thrombocytopenic purpura pathogenesis and diagnosis. 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Thrombocytopenic Purpura"

1

Raj, Satish R., S. R. Wayne Chen, Robert S. Sheldon, et al. "Thrombocytopenia and Thrombotic Thrombocytopenic Purpura." In Encyclopedia of Molecular Mechanisms of Disease. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_1737.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Thornton, Donald E., and Earl N. Metz. "Thrombotic Thrombocytopenic Purpura." In Contemporary Internal Medicine. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4757-9823-4_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rosenberg, Nurit, Yulia Einav, and Boris Shenkman. "Autoimmune Thrombocytopenic Purpura." In Diagnostic Criteria in Autoimmune Diseases. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-60327-285-8_100.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Massey, Gita V. "Idiopathic Thrombocytopenic Purpura." In Compendium of Inflammatory Diseases. Springer Basel, 2016. http://dx.doi.org/10.1007/978-3-7643-8550-7_95.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hamburger, Joshua Zevy, and Yaakov Beilin. "Thrombotic Thrombocytopenic Purpura." In Consults in Obstetric Anesthesiology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-59680-8_162.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Taylor, Jeffrey S. "Idiopathic Thrombocytopenic Purpura." In Pediatric Surgery. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-04340-1_53.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Taylor, Jeffrey S. "Thrombotic Thrombocytopenic Purpura." In Pediatric Surgery. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-04340-1_54.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Edozien, Leroy C. "Immune thrombocytopenic purpura." In The Labour Ward Handbook, 3rd ed. CRC Press, 2023. http://dx.doi.org/10.1201/9781315099897-69.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Massey, Gita V. "Idiopathic Thrombocytopenic Purpura." In Encyclopedia of Inflammatory Diseases. Springer Basel, 2016. http://dx.doi.org/10.1007/978-3-0348-0620-6_95-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Leung, Anskar Y. H., and Edmond S. K. Ma. "Thrombotic Thrombocytopenic Purpura." In Haematology and the Asian Patient. CRC Press, 2024. http://dx.doi.org/10.1201/9781003325413-49.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Thrombocytopenic Purpura"

1

Pantino, M. K., J. Kamau, E. Paul, et al. "Atezolizumab-Induced Thrombocytopenic Thrombotic Purpura." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2906.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jones, Adisa, and Gerardo Carino. "Weil's Disease Masquerading As Thrombotic Thrombocytopenic Purpura (TTP)." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3220.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Arnaout, Karim, Mustapha Khalife, and Amr Hanbali. "Abstract 1885: Malignancies associated with immune thrombocytopenic purpura." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-1885.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chediak, J., J. Eldridge, D. Sobel, B. Maxey, J. Baron, and M. C. Telfer. "FURTHER EVIDENCES OF VON WILLEBRAND FACTOR INVOLVEMENT IN THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644587.

Full text
Abstract:
Laboratory findings of TTP include severe thrombocytopenia and marked anemia due to intravascular hemolysis. The pathogenesis of the thrombocytopenia is poorly understood. Possible mechanisms include the presence of a platelet aggregating factor (JCI 76:1330, 1935), a calcium dependent protease (Blood 63:310a, 1986), abnormal prostaglandin production or metabolism, and an excessive consumption of high molecular weight forms of von Uillebrand factor (VUF). Von Willebrand factor proteins from 12 patients (pts) diagnosed as having TTP were studied. They include 8 females and 4 males; nine were st
APA, Harvard, Vancouver, ISO, and other styles
5

Chowdhury, J. M., M. Errandi, A. Brown, C. Quinn, A. Kasarabada, and C. S. King. "Thrombotic Thrombocytopenic Purpura in a Post Cardiac Surgery Patient." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2925.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Qurashi, H. M. S., T. Saleem, I. Kovalenko, et al. "A Deadly Duo; Thrombotic Thrombocytopenic Purpura and Antiphospholipid Syndrome." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4229.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Santos, João Vitor Ribeiro dos, Mariana Spitz, and Ana Carolina Andorinho. "Stroke secondary to thrombotic microangiopathy." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.300.

Full text
Abstract:
Introduction: Thrombotic thrombocytopenic purpura (TTP) is a hematological disease resulting from the ADAMTS 13 plasmatic protein deficit. It can be congenital or sporadic, and is usually autoimmune. Pathological platelet adhesion occurs, leading to microthrombi in capillary and arterial circulation, microangiopathic anemia and ischemia. The clinical picture includes thrombocytopenia, renal dysfunction, fluctuating neurological symptoms, microangiopathic hemolytic anemia, and fever. Methods: Case report of a 51-year-old male hypertensive patient, diagnosed with idiopathic thrombocytopenic purp
APA, Harvard, Vancouver, ISO, and other styles
8

Hinestroza, M., and A. D. Can. "Sickle Cell Crisis or Thrombotic Thrombocytopenic Purpura: A Diagnostic Dilemma." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7208.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bergamaschi, Thaisa Frediani, Larissa Felcar Hil, Isabel Cristina Hilgert Genz, et al. "IDIOPATHIC THROMBOCYTOPENIC PURPURA ASSOCIATED WITH MULTIPLE SPLEENS: A CASE REPORT." In XL Congresso Brasileiro de Reumatologia. Sociedade Brasileiro de Reumatologia, 2023. http://dx.doi.org/10.47660/cbr.2023.2406.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pinoti, Murilo Freire, Thiago Scoppetta, Sandro Matas, and Mateus Boaventura. "Concomitant multiple sclerosis and idiopathic thrombocytopenic purpura treated with ocrelizumab." In PROCEEDINGS OF THE BCTRIMS 24TH ANNUAL MEETING. Galoa, 2023. http://dx.doi.org/10.17648/bctrims-2023-167483.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Thrombocytopenic Purpura"

1

Pelletier, Joseph P., Oluwole Fadare, and Yanyun Wu. Post-Renal Transplant Thrombotic Thrombocytopenic Purpura (TTP): Attributable to Immunosuppression or Graft Rejection? Report of Three Cases and Literature Review. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada429608.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chen, Bin, Xihong Li, Dongqiong Xiao, Ruixi Zhou, and Yupeng Lei. Efficacy and safety of caplacizumab in the treatment of thrombotic thrombocytopenic purpura: a meta-analysis of systematic reviews based on high-quality randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.5.0149.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ren, Xiangge, Mengmeng Zhang, Jinyu Ni, and Wensheng Zhai. Efficacy, safety and economy of different doses of intravenous immunoglobulin in the treatment of idiopathic thrombocytopenic purpura in children: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.7.0126.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gidengil, Courtney, Matthew Bidwell Goetz, Margaret Maglione, et al. Safety of Vaccines Used for Routine Immunization in the United States: An Update. Agency for Healthcare Research and Quality (AHRQ), 2021. http://dx.doi.org/10.23970/ahrqepccer244.

Full text
Abstract:
Objective. To conduct a systematic review of the literature on the safety of vaccines recommended for routine immunization in the United States, updating the 2014 Agency for Healthcare Research and Quality (AHRQ) report on the topic. Data sources. We searched MEDLINE®, Embase®, CINAHL®, Cochrane CENTRAL, Web of Science, and Scopus through November 9, 2020, building on the prior 2014 report; reviewed existing reviews, trial registries, and supplemental material submitted to AHRQ; and consulted with experts. Review methods. This report addressed three Key Questions (KQs) on the safety of vaccine
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Thrombocytopenic Purpura' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography